122 related articles for article (PubMed ID: 31298051)
1. Cucurbitacin E glucoside from
Basha SZ; Mohamed GA; Abdel-Naim AB; Hasan A; Abdel-Lateff A
Drug Chem Toxicol; 2021 Sep; 44(5):533-543. PubMed ID: 31298051
[TBL] [Abstract][Full Text] [Related]
2. Synthesis of Cinnamyl and Caffeoyl Derivatives of Cucurbitacin-Eglycoside Isolated from Citrullus colocynthis Fruits and their Structures Antioxidant and Anti-inflammatory Activities Relationship.
Hussein MA; El-Gizawy HA; Gobba NAEK; Mosaad YO
Curr Pharm Biotechnol; 2017 Nov; 18(8):677-693. PubMed ID: 28982326
[TBL] [Abstract][Full Text] [Related]
3. Amelioration of testosterone induced benign prostatic hyperplasia by Prunus species.
Jena AK; Vasisht K; Sharma N; Kaur R; Dhingra MS; Karan M
J Ethnopharmacol; 2016 Aug; 190():33-45. PubMed ID: 27235020
[TBL] [Abstract][Full Text] [Related]
4. Auraptene nanoparticles ameliorate testosterone-induced benign prostatic hyperplasia in rats: Emphasis on antioxidant, anti-inflammatory, proapoptotic and PPARs activation effects.
Almukadi H; Eid BG; Shaik RA; Abdel-Naim AB; Esmat A
Biomed Pharmacother; 2021 Nov; 143():112199. PubMed ID: 34649341
[TBL] [Abstract][Full Text] [Related]
5. Abacopteris penangiana exerts testosterone-induced benign prostatic hyperplasia protective effect through regulating inflammatory responses, reducing oxidative stress and anti-proliferative.
Yang X; Yuan L; Xiong C; Yin C; Ruan J
J Ethnopharmacol; 2014 Nov; 157():105-13. PubMed ID: 25260581
[TBL] [Abstract][Full Text] [Related]
6. Effects of a co-micronized composite containing palmitoylethanolamide and polydatin in an experimental model of benign prostatic hyperplasia.
Cordaro M; Impellizzeri D; Siracusa R; Gugliandolo E; Fusco R; Inferrera A; Esposito E; Di Paola R; Cuzzocrea S
Toxicol Appl Pharmacol; 2017 Aug; 329():231-240. PubMed ID: 28610993
[TBL] [Abstract][Full Text] [Related]
7. Inhibitory effects of Ponciri Fructus on testosterone-induced benign prostatic hyperplasia in rats.
Jeon WY; Kim OS; Seo CS; Jin SE; Kim JA; Shin HK; Kim YU; Lee MY
BMC Complement Altern Med; 2017 Aug; 17(1):384. PubMed ID: 28774334
[TBL] [Abstract][Full Text] [Related]
8. Inhibitory Effect of Artemisinin on Testosterone Propionate Induced Benign Prostatic Hyperplasia.
Solanki A; Patel S; Solanki N; Shah U
Curr Drug Discov Technol; 2021; 18(4):518-524. PubMed ID: 32532194
[TBL] [Abstract][Full Text] [Related]
9. Febuxostat attenuates testosterone-induced benign prostatic hyperplasia in rats via inhibiting JAK/STAT axis.
Abo-Youssef AM; Afify H; Azouz AA; Abdel-Rahman HM; Abdel-Naim AB; Allam S
Life Sci; 2020 Nov; 260():118414. PubMed ID: 32926929
[TBL] [Abstract][Full Text] [Related]
10. The anti-hyperplasia, anti-oxidative and anti-inflammatory properties of Qing Ye Dan and swertiamarin in testosterone-induced benign prostatic hyperplasia in rats.
Wu X; Gu Y; Li L
Toxicol Lett; 2017 Jan; 265():9-16. PubMed ID: 27866977
[TBL] [Abstract][Full Text] [Related]
11. Asteris Radix et Rhizoma suppresses testosterone-induced benign prostatic hyperplasia in rats by regulating apoptosis and inflammation.
Rho J; Seo CS; Park HS; Jeong HY; Moon OS; Seo YW; Son HY; Won YS; Kwun HJ
J Ethnopharmacol; 2020 Jun; 255():112779. PubMed ID: 32209388
[TBL] [Abstract][Full Text] [Related]
12. Amelioration of testosterone-induced benign prostatic hyperplasia using febuxostat in rats: The role of VEGF/TGFβ and iNOS/COX-2.
Abdel-Aziz AM; Gamal El-Tahawy NF; Salah Abdel Haleem MA; Mohammed MM; Ali AI; Ibrahim YF
Eur J Pharmacol; 2020 Dec; 889():173631. PubMed ID: 33031799
[TBL] [Abstract][Full Text] [Related]
13. Diacerein ameliorates testosterone-induced benign prostatic hyperplasia in rats: Effect on oxidative stress, inflammation and apoptosis.
El-Sherbiny M; El-Shafey M; El-Din El-Agawy MS; Mohamed AS; Eisa NH; Elsherbiny NM
Int Immunopharmacol; 2021 Nov; 100():108082. PubMed ID: 34450401
[TBL] [Abstract][Full Text] [Related]
14. Paljung-San, a traditional herbal medicine, attenuates benign prostatic hyperplasia in vitro and in vivo.
Park E; Lee MY; Jeon WY; Seo CS; You S; Shin HK
J Ethnopharmacol; 2018 May; 218():109-115. PubMed ID: 29501675
[TBL] [Abstract][Full Text] [Related]
15. Qianliexin capsule exerts anti-inflammatory activity in chronic non-bacterial prostatitis and benign prostatic hyperplasia via NF-κB and inflammasome.
Zang L; Tian F; Yao Y; Chen Y; Shen Y; Han M; Meng Z; Fan S; Zhang X; Cai T; Gao Q; Zhang Y; Lu J
J Cell Mol Med; 2021 Jun; 25(12):5753-5768. PubMed ID: 33982874
[TBL] [Abstract][Full Text] [Related]
16. Cordycepin Attenuates Testosterone-Induced Benign Prostatic Hyperplasia in Rats via Modulation of AMPK and AKT Activation.
Alamoudi AJ; Alessi SA; Rizg WY; Jali AM; Safhi AY; Sabei FY; Alshehri S; Hosny KM; Abdel-Naim AB
Pharmaceutics; 2022 Aug; 14(8):. PubMed ID: 36015278
[TBL] [Abstract][Full Text] [Related]
17. 6-Paradol Alleviates Testosterone-Induced Benign Prostatic Hyperplasia in Rats by Inhibiting AKT/mTOR Axis.
Binmahfouz LS; Almukadi H; Alamoudi AJ; El-Halawany AM; Abdallah HM; Algandaby MM; Mohamed GA; Ibrahim SRM; Alghamdi FA; Al-Shaeri M; Abdel-Naim AB
Plants (Basel); 2022 Oct; 11(19):. PubMed ID: 36235468
[TBL] [Abstract][Full Text] [Related]
18. Icariin ameliorates metabolic syndrome-induced benign prostatic hyperplasia in rats.
Aljehani AA; Albadr NA; Nasrullah MZ; Neamatallah T; Eid BG; Abdel-Naim AB
Environ Sci Pollut Res Int; 2022 Mar; 29(14):20370-20378. PubMed ID: 34734339
[TBL] [Abstract][Full Text] [Related]
19. Ursolic acid reduces prostate size and dihydrotestosterone level in a rat model of benign prostatic hyperplasia.
Shin IS; Lee MY; Jung DY; Seo CS; Ha HK; Shin HK
Food Chem Toxicol; 2012 Mar; 50(3-4):884-8. PubMed ID: 22266360
[TBL] [Abstract][Full Text] [Related]
20. Growth inhibitory activity of cucurbitacin glucosides isolated from Citrullus colocynthis on human breast cancer cells.
Tannin-Spitz T; Grossman S; Dovrat S; Gottlieb HE; Bergman M
Biochem Pharmacol; 2007 Jan; 73(1):56-67. PubMed ID: 17049494
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
